chr11:32387775:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr11:32,409,321-32,457,110 |
| hg38 | chr11:32,387,775-32,435,564 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.008 | squamous cell carcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| 0.120 | Colonic Neoplasms | NA | CTD_human | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| <0.001 | cryptorchidism | NA | BeFree | Detail | |
| <0.001 | Diabetic Nephropathy | NA | BeFree | Detail | |
| <0.001 | Down syndrome | NA | BeFree | Detail | |
| 0.005 | Endometrial Neoplasms | NA | LHGDN | Detail | |
| <0.001 | endometriosis | NA | BeFree | Detail | |
| <0.001 | Eosinophilia | NA | BeFree | Detail | |
| 0.002 | Disorder of eye | NA | GAD | Detail | |
| <0.001 | Fanconi anemia | NA | BeFree | Detail | |
| 0.003 | Fibrosis | NA | LHGDN | Detail | |
| 0.124 | glioblastoma | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.004 | Glioma | NA | BeFree,LHGDN | Detail | |
| 0.123 | glomerulonephritis | NA | CTD_human,LHGDN | Detail | |
| 0.008 | Focal glomerulosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | gonadal dysgenesis | NA | BeFree | Detail | |
| <0.001 | hemangioma | NA | BeFree | Detail | |
| <0.001 | Hemangiosarcoma | NA | BeFree | Detail | |
| <0.001 | Hematological Disease | We determined the level of WT1 gene expression in 130 children, adolescents and ... | BeFree | 25238704 | Detail |
| 0.120 | Diaphragmatic hernia | NA | BeFree,CTD_human | Detail | |
| <0.001 | HIV Infections | NA | BeFree | Detail | |
| 0.003 | hyperparathyroidism | NA | BeFree,LHGDN | Detail | |
| <0.001 | Hypertensive disease | NA | BeFree | Detail | |
| <0.001 | male infertility | Large multicenter studies are needed to fully assess the contribution of WT1 gen... | BeFree | 25451826 | Detail |
| 0.001 | Kidney Diseases | NA | BeFree | Detail | |
| 0.003 | Kidney Failure, Chronic | NA | BeFree,GAD | Detail | |
| 0.007 | Kidney Neoplasm | Studies of WT1-knockout mice confirmed the important role of WT1 in the pathogen... | BeFree,GAD | 25189877 | Detail |
| <0.001 | leiomyosarcoma | NA | BeFree | Detail | |
| 0.143 | leukemia | Of these, 230 were monitored concurrently for minimal residual disease (MRD) by ... | BeFree,CTD_human,LHGDN | 24631740 | Detail |
| <0.001 | Leukemia, Eosinophilic, Acute | NA | BeFree | Detail | |
| <0.001 | lymphoid leukemia | NA | BeFree | Detail | |
| 0.002 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, Lymphocytic, Acute, L1 | Studies of WT1-knockout mice confirmed the important role of WT1 in the pathogen... | BeFree | 25189877 | Detail |
| 0.008 | myeloid leukemia | NA | BeFree,GAD | Detail | |
| 0.128 | Myeloid Leukemia, Chronic | NA | BeFree,CTD_human,GAD | Detail | |
| 0.002 | Leukemia, Myelomonocytic, Chronic | NA | GAD | Detail | |
| <0.001 | Liver diseases | NA | BeFree | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.120 | Lung Neoplasms | NA | CTD_human | Detail | |
| 0.006 | lymphoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Malignant neoplasm of stomach | Immunohistochemical study showed that Rad54 and XRCC2 proteins were highly expre... | BeFree | 25418835 | Detail |
| 0.003 | medulloblastoma | NA | LHGDN | Detail | |
| 0.003 | melanoma | A subtraction tolerization method of immunization allowed for Wilms' tumor prote... | BeFree,LHGDN | 25205401 | Detail |
| <0.001 | meningioma | NA | BeFree | Detail | |
| 0.006 | Mental Retardation | NA | BeFree | Detail | |
| <0.001 | Myelodysplasia | NA | BeFree | Detail | |
| 0.008 | Neoplasm Metastasis | NA | LHGDN | Detail | |
| 0.002 | Pathologic Neovascularization | NA | GAD | Detail | |
| 0.444 | nephroblastoma | Of these, 230 were monitored concurrently for minimal residual disease (MRD) by ... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 24631740 | Detail |
| 0.444 | nephroblastoma | Loss of BRCA1 expression and Wilms tumor 1 (WT-1) overexpression were detected b... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 24681740 | Detail |
| 0.444 | nephroblastoma | To investigate frequency and prognostic impact of Wilms tumor 1 (WT1) mutations ... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25110071 | Detail |
| 0.444 | nephroblastoma | Studies of WT1-knockout mice confirmed the important role of WT1 in the pathogen... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25189877 | Detail |
| 0.444 | nephroblastoma | Two CpGs located in the genes Wilms' tumor 1 (WT1) and potassium voltage-gated c... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25429063 | Detail |
| 0.444 | nephroblastoma | The expression of the Wilms tumor 1 (WT1), lutropin/choriogonadotropin receptor ... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25434310 | Detail |
| 0.444 | nephroblastoma | The Wilms' tumor 1 (WT1) expression has been recognized in a substantial number ... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25572170 | Detail |
| 0.444 | nephroblastoma | Individuals with WT1-positive acute myeloid leukemia (AML) in first (CR1) or sec... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25802083 | Detail |
| 0.444 | nephroblastoma | Wilms' tumor gene 1 (WT1) protein is a promising tumor-associated antigen for ca... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25835542 | Detail |
| 0.444 | nephroblastoma | We also demonstrate that WT1(+) cells accumulate in fibrotic lung lesions, using... | BeFree,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 26371248 | Detail |
| 0.026 | nephrotic syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.120 | neurilemmoma | NA | CTD_human | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| 0.004 | osteosarcoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.122 | Pancreatic Neoplasm | NA | CTD_human,GAD | Detail | |
| 0.003 | Preleukemia | NA | BeFree,GAD | Detail | |
| <0.001 | pseudohermaphroditism | NA | BeFree | Detail | |
| <0.001 | pulmonary fibrosis | We also demonstrate that WT1(+) cells accumulate in fibrotic lung lesions, using... | BeFree | 26371248 | Detail |
| <0.001 | kidney failure | NA | BeFree | Detail | |
| <0.001 | retinoblastoma | NA | BeFree | Detail | |
| <0.001 | rhabdomyosarcoma | Among neoplastic tissues, WT1 has been documented in the cytoplasm of benign and... | BeFree | 24709316 | Detail |
| 0.003 | Sclerosis | NA | LHGDN | Detail | |
| 0.003 | Sertoli cell tumor | NA | LHGDN | Detail | |
| 0.003 | Thyroid Neoplasm | NA | LHGDN | Detail | |
| 0.002 | Tobacco use disorder | NA | GAD | Detail | |
| 0.002 | Turner syndrome | NA | BeFree | Detail | |
| 0.001 | Urogenital Abnormalities | NA | BeFree | Detail | |
| 0.003 | Fibromatosis, Aggressive | NA | BeFree,LHGDN | Detail | |
| 0.002 | Neoplasms, Second Primary | NA | GAD | Detail | |
| 0.120 | Ovarian Failure, Premature | NA | CTD_human | Detail | |
| 0.005 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | Vascular anomaly | NA | BeFree | Detail | |
| <0.001 | Congenital malformation of genital organs | NA | BeFree | Detail | |
| <0.001 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | follicular adenoma | NA | BeFree | Detail | |
| <0.001 | Germ cell tumor | NA | BeFree | Detail | |
| 0.246 | WAGR syndrome | NA | BeFree,CTD_human,GAD,ORPHANET | Detail | |
| <0.001 | Idiopathic hypereosinophilic syndrome | NA | BeFree | Detail | |
| <0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
| 0.005 | smooth muscle tumor | NA | LHGDN | Detail | |
| 0.001 | gonadoblastoma | NA | BeFree | Detail | |
| <0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
| <0.001 | Sex cord-stromal tumor | NA | BeFree | Detail | |
| <0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
| 0.002 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
| <0.001 | Congenital defects | NA | BeFree | Detail | |
| 0.120 | congenital diaphragmatic hernia | NA | BeFree,CTD_human | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| 0.003 | Gastrointestinal Stromal Tumors | NA | LHGDN | Detail | |
| <0.001 | Defect of diaphragm | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of lung | Subsequent research has shown that the WT1 gene in many other cases acts as an o... | BeFree | 25189877 | Detail |
| <0.001 | Myofibroblastoma | Wilms' tumor protein (WT1) in mammary myofibroblastoma: an immunohistochemical s... | BeFree | 24709316 | Detail |
| 0.005 | Neoplasm, Residual | Of these, 230 were monitored concurrently for minimal residual disease (MRD) by ... | BeFree | 24631740 | Detail |
| <0.001 | disseminated eosinophilic collagen disease | NA | BeFree | Detail | |
| <0.001 | Dermatomyositis, Childhood Type | NA | BeFree | Detail | |
| <0.001 | Renal glomerular disease | NA | BeFree | Detail | |
| <0.001 | Metastatic melanoma | The peptide WT1-pTj was also protective in vivo in a metastatic melanoma model a... | BeFree | 25205401 | Detail |
| <0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
| <0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation st... | BeFree | 25025131 | Detail |
| <0.001 | extraosseous Ewings sarcoma-primitive neuroepithelial tumor | NA | BeFree | Detail | |
| 0.003 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
| 0.130 | desmoplastic small round cell tumor | NA | BeFree,ORPHANET | Detail | |
| <0.001 | Segmental glomerulosclerosis | NA | BeFree | Detail | |
| <0.001 | inflammatory myofibroblastic tumor | Accordingly, we studied immunohistochemically the potential expression of WT1 in... | BeFree | 24709316 | Detail |
| <0.001 | malignant fibrous histiocytoma | NA | BeFree | Detail | |
| <0.001 | sarcomatoid mesothelioma | NA | BeFree | Detail | |
| 0.003 | Endometrial Stromal Tumors | NA | LHGDN | Detail | |
| <0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
| <0.001 | malignant mesothelioma | NA | BeFree | Detail | |
| <0.001 | Malignant Mesothelioma of Peritoneum | NA | BeFree | Detail | |
| <0.001 | chronic eosinophilic leukemia | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| 0.002 | Steroid-resistant nephrotic syndrome | NA | BeFree | Detail | |
| <0.001 | Bilateral Cryptorchidism | As far as is known, this is the smallest deletion as-yet described encompassing ... | BeFree | 24912414 | Detail |
| <0.001 | Chromosome 8, trisomy | NA | BeFree | Detail | |
| <0.001 | Sleep Apnea, Obstructive | NA | BeFree | Detail | |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant glioma | NA | BeFree | Detail | |
| <0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
| 0.007 | Carcinogenesis | Wilms tumor 1 (WT1) protein, a transcription factor, is overexpressed in many tu... | BeFree | 25219513 | Detail |
| 0.002 | Leukemogenesis | NA | BeFree | Detail | |
| <0.001 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.003 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | Subsequent research has shown that the WT1 gene in many other cases acts as an o... | BeFree | 25189877 | Detail |
| <0.001 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | NA | BeFree | Detail | |
| <0.001 | colon carcinoma | NA | BeFree | Detail | |
| <0.001 | stomach carcinoma | Immunohistochemical study showed that Rad54 and XRCC2 proteins were highly expre... | BeFree | 25418835 | Detail |
| <0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
| <0.001 | Idiopathic Inflammatory Myopathies | NA | BeFree | Detail | |
| <0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
| 0.003 | hypospadias | NA | BeFree,GAD | Detail | |
| <0.001 | Testicular malignant germ cell tumor | NA | BeFree | Detail | |
| <0.001 | Post MI | NA | BeFree | Detail | |
| <0.001 | Epithelioid mesothelioma, malignant | NA | BeFree | Detail | |
| 0.003 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
| 0.573 | Denys-Drash syndrome | Heterozygous missense mutations in the WT1 gene that affect the function of the ... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,MGD,ORPHANET,UNIPROT | 25613702 | Detail |
| <0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
| 0.010 | sarcoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | extraskeletal myxoid chondrosarcoma | NA | BeFree | Detail | |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| 0.003 | Hepatic Insufficiency | NA | LHGDN | Detail | |
| <0.001 | Eosinophilic disorder | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Nephrogenic rest | NA | BeFree | Detail | |
| <0.001 | Childhood Renal Neoplasm | NA | BeFree | Detail | |
| <0.001 | Malignant Vascular Neoplasm | Among neoplastic tissues, WT1 has been documented in the cytoplasm of benign and... | BeFree | 24709316 | Detail |
| <0.001 | mesenchymal cell neoplasm | The present study shows that mammary epithelioid cell MFB should be added to the... | BeFree | 24709316 | Detail |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | skull base meningioma | NA | BeFree | Detail | |
| <0.001 | Spindle Cell Neoplasm | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| 0.142 | Mammary Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | Autism Spectrum Disorders | NA | BeFree | Detail | |
| 0.003 | Desmoplastic | NA | BeFree | Detail | |
| <0.001 | colorectal cancer | NA | BeFree | Detail | |
| 0.003 | hypereosinophilic syndrome | NA | BeFree,LHGDN | Detail | |
| <0.001 | Non-Malignant Ascites Adverse Event | NA | BeFree | Detail | |
| <0.001 | Glioblastoma multiforme | This review describes the role of the Wilms tumor 1 gene (WT1) and its relations... | BeFree | 25434383 | Detail |
| <0.001 | Disorder characterized by eosinophilia | NA | BeFree | Detail | |
| <0.001 | Penile hypospadias | NA | BeFree | Detail | |
| <0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
| <0.001 | MYELOPROLIFERATIVE SYNDROME, TRANSIENT | NA | BeFree | Detail | |
| 0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
| <0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
| 0.004 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,LHGDN | Detail | |
| 0.004 | liver carcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
| <0.001 | 46, XY Disorders of Sex Development | NA | BeFree | Detail | |
| <0.001 | Mixed phenotype acute leukemia | NA | BeFree | Detail | |
| 0.001 | Bilateral Wilms Tumor | NA | BeFree | Detail | |
| 0.120 | Meacham Winn Culler syndrome | NA | CTD_human | Detail | |
| <0.001 | Juvenile dermatomyositis | NA | BeFree | Detail | |
| 0.120 | Deletion 11p13 | NA | ORPHANET | Detail | |
| <0.001 | myeloid neoplasm | Peptide vaccines are capable of eliciting immune responses targeting tumor-assoc... | BeFree | 25802083 | Detail |
| 0.240 | Nephrotic syndrome, type 4 | NA | CTD_human,UNIPROT | Detail | |
| 0.002 | myelodysplastic syndrome | NA | GAD | Detail | |
| <0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
| <0.001 | Triple Negative Breast Neoplasms | Importantly, we stratify TNBCs into three distinct methylation clusters associat... | BeFree | 25641231 | Detail |
| 0.002 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
| 0.002 | Congenital Abnormality | NA | BeFree | Detail | |
| 0.003 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | adenoma | NA | BeFree | Detail | |
| 0.005 | Alzheimer's disease | NA | GAD,LHGDN | Detail | |
| <0.001 | Anaplasia | NA | BeFree | Detail | |
| 0.002 | aniridia | NA | BeFree | Detail | |
| <0.001 | autistic disorder | NA | BeFree | Detail | |
| <0.001 | Beckwith-Wiedemann syndrome | NA | BeFree | Detail | |
| 0.001 | Blast Phase | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of breast | NA | BeFree | Detail | |
| 0.003 | Carcinoid Tumor | NA | LHGDN | Detail | |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | Immunohistochemical study showed that Rad54 and XRCC2 proteins were highly expre... | BeFree | 25418835 | Detail |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We determined the level of WT1 gene expression in 130 children, adolescents and young adults with ma... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Large multicenter studies are needed to fully assess the contribution of WT1 genetic alterations to ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Studies of WT1-knockout mice confirmed the important role of WT1 in the pathogenesis of Wilms' tumou... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Of these, 230 were monitored concurrently for minimal residual disease (MRD) by flow cytometry (FCM)... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Studies of WT1-knockout mice confirmed the important role of WT1 in the pathogenesis of Wilms' tumou... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Immunohistochemical study showed that Rad54 and XRCC2 proteins were highly expressed in the majority... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A subtraction tolerization method of immunization allowed for Wilms' tumor protein-1 (WT1) identific... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Of these, 230 were monitored concurrently for minimal residual disease (MRD) by flow cytometry (FCM)... | DisGeNET | Detail |
| Loss of BRCA1 expression and Wilms tumor 1 (WT-1) overexpression were detected by immunohistochemica... | DisGeNET | Detail |
| To investigate frequency and prognostic impact of Wilms tumor 1 (WT1) mutations (mut), we analyzed 3... | DisGeNET | Detail |
| Studies of WT1-knockout mice confirmed the important role of WT1 in the pathogenesis of Wilms' tumou... | DisGeNET | Detail |
| Two CpGs located in the genes Wilms' tumor 1 (WT1) and potassium voltage-gated channel, KQT-like sub... | DisGeNET | Detail |
| The expression of the Wilms tumor 1 (WT1), lutropin/choriogonadotropin receptor (LHR), 17-β-hydroxys... | DisGeNET | Detail |
| The Wilms' tumor 1 (WT1) expression has been recognized in a substantial number of acute myeloid leu... | DisGeNET | Detail |
| Individuals with WT1-positive acute myeloid leukemia (AML) in first (CR1) or second (CR2) remission ... | DisGeNET | Detail |
| Wilms' tumor gene 1 (WT1) protein is a promising tumor-associated antigen for cancer immunotherapy. | DisGeNET | Detail |
| We also demonstrate that WT1(+) cells accumulate in fibrotic lung lesions, using two different mouse... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We also demonstrate that WT1(+) cells accumulate in fibrotic lung lesions, using two different mouse... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Among neoplastic tissues, WT1 has been documented in the cytoplasm of benign and malignant vascular ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Subsequent research has shown that the WT1 gene in many other cases acts as an oncogene, most promin... | DisGeNET | Detail |
| Wilms' tumor protein (WT1) in mammary myofibroblastoma: an immunohistochemical study. | DisGeNET | Detail |
| Of these, 230 were monitored concurrently for minimal residual disease (MRD) by flow cytometry (FCM)... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The peptide WT1-pTj was also protective in vivo in a metastatic melanoma model and peptide-stimulate... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell re... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Accordingly, we studied immunohistochemically the potential expression of WT1 in mammary myofibrobla... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| As far as is known, this is the smallest deletion as-yet described encompassing the WT1 gene and was... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Wilms tumor 1 (WT1) protein, a transcription factor, is overexpressed in many tumors and plays a rol... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Subsequent research has shown that the WT1 gene in many other cases acts as an oncogene, most promin... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Immunohistochemical study showed that Rad54 and XRCC2 proteins were highly expressed in the majority... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Heterozygous missense mutations in the WT1 gene that affect the function of the wild-type allele hav... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Among neoplastic tissues, WT1 has been documented in the cytoplasm of benign and malignant vascular ... | DisGeNET | Detail |
| The present study shows that mammary epithelioid cell MFB should be added to the list of mesenchymal... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This review describes the role of the Wilms tumor 1 gene (WT1) and its relationship to GBM. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Peptide vaccines are capable of eliciting immune responses targeting tumor-associated antigens such ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Importantly, we stratify TNBCs into three distinct methylation clusters associated with better or wo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Immunohistochemical study showed that Rad54 and XRCC2 proteins were highly expressed in the majority... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg38
- Position
- chr11:32,387,775-32,435,564
- Variant Type
- snv
Genome browser